Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular docking

Fig. 3

Biochanin A and prediction of key therapeutic targets for endothelial dysfunction. A Venn diagram of the target gene of biochanin A and endothelial dysfunction; B PPI network of the co-targets of biochanin A and endothelial dysfunction; C The top 30 proteins in PPI protein interaction with other proteins

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us